Seeing Is Believing

Currently out of the existing stock ratings of Kristen Stewart, 52 are a BUY (58.43%), 14 are a SELL (15.73%), 23 are a HOLD (25.84%).
Analyst Kristen Stewart, currently employed at C. L. KING, carries an average stock price target met ratio of 75.04% that have a potential upside of 23.13% achieved within 350 days.
Kristen Stewart’s has documented 176 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TFX, Teleflex at 04-Nov-2024.
Analyst best performing recommendations are on AVNS (AVANOS MEDICAL).
The best stock recommendation documented was for AVNS (AVANOS MEDICAL) at 4/13/2020. The price target of $30 was fulfilled within 1 day with a profit of $1.62 (5.71%) receiving and performance score of 57.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Dec-2018
$142
$29.79 (26.55%)
$169
22 days ago
(02-Feb-2026)
18/27 (66.67%)
$32.59 (29.79%)
511
Buy Since 06-Jun-2019
$140
$27.79 (24.77%)
$160
1 months 1 days ago
(23-Jan-2026)
12/16 (75%)
$32.58 (30.33%)
485
Buy Since 19-Sep-2024
$135
$22.79 (20.31%)
$150
1 months 1 days ago
(23-Jan-2026)
2/5 (40%)
$27.58 (25.67%)
143
Buy Since 27-Jun-2018
$125
$12.79 (11.40%)
$154
1 months 1 days ago
(23-Jan-2026)
3/6 (50%)
$17.58 (16.37%)
595
Buy Since 18-Jul-2018
$138
$25.79 (22.98%)
$142
1 months 1 days ago
(23-Jan-2026)
9/15 (60%)
$30.58 (28.47%)
310
What Year was the first public recommendation made by Kristen Stewart?